Tyrosine hydroxylase phosphorylation in vivo.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic and animal research
PubMed 30714137 · doi:10.1111/jnc.14675
What was done
This is a narrative review synthesizing literature on in vivo tyrosine hydroxylase (TH) phosphorylation. It outlines methodologies (animal models, sacrifice procedures, tissue preparation, assays for TH protein, phosphorylation, and activation), regulatory mechanisms (kinases, phosphatases, stoichiometry, binding proteins, subcellular localization), and site-specific phosphorylation (serine residues 8, 19, 31, and 40) across catecholaminergic tissues, including the adrenal medulla, nigrostriatal pathway, and mesolimbic pathway.
What was found
The abstract reports no numerical findings or quantitative effect sizes. It describes the regulatory framework of TH phosphorylation at Ser8, Ser19, Ser31, and Ser40, and highlights that in vivo phosphorylation undergoes acute and prolonged changes across distinct catecholaminergic tissues.
Why it matters
Tyrosine hydroxylase is the rate-limiting enzyme in catecholamine biosynthesis (dopamine, noradrenaline, adrenaline). Understanding its in vivo phosphorylation dynamics clarifies physiological regulation of neurotransmitter production beyond in vitro model systems.
Limits
The abstract provides no empirical data, sample sizes, or quantitative meta-analytic pooling. As a narrative review focused on preclinical bench and animal methodologies, findings describe basic biochemical mechanisms rather than direct human clinical outcomes.
Cited by
- supports Dopamine, norepinephrine, and epinephrine are catecholamines synthesized biochemically from one another via enzymatic cleavage/modification.